Home Molecular Dx RNA

RNA

Latest
Researchers at The University of Texas MD Anderson Cancer Center have found that a rare resistance mutation first thought to appear in melanoma (pictured) following treatment with a targeted therapy has instead turned out to be hiding in the tumor all along. [Definiens]
RNA

Melanoma Diagnosis Could be More Precise Using miRNA Biomarkers

RNA

Myriad Partners with LCPMH to Assess Clinical Utility of Prolaris Prostate...

RNA

Mammoth Milestone: CRISPR-Based Dx Developer Licenses 2 U. of California Patents

RNA

Oxford Nanopore Opens Factory to Meet Demand for MinION, Other DNA/RNA...

dementia
RNA

RNA Splicing Mutations Alter Tau Protein Isoforms in Alzheimer’s and Parkinson’s

GenomeDx Biosciences has agreed to pay the U.S. federal government $1.99 million to settle allegations that it submitted false claims to Medicare for the Decipher post-operative genetic test for prostate cancer patients. [National Cancer Institute
RNA

GenomeDx to Pay $1.99M to Settle Medicare Billing Allegations

Source: ROGER HARRIS/SCIENCE PHOTO LIBRARY/Getty Images
RNA

Better View of Microbiome Delivered by New tRNA Sequencing Technique

Messenger RNA (mRNA) therapy developer Moderna has raised at least $604.3 million in gross proceeds in the largest initial public offering for a biotech. [© Argus/Fotolia]
RNA

mRNA Therapy Developer Moderna Raises $604M in Largest-Ever Biotech IPO

Children’s Hospital of Philadelphia has launched the Center for Computational and Genomic Medicine
RNA

CHOP Launches Center for Computational and Genomic Medicine

Source: KATERYNA KON/SCIENCE PHOTO LIBRARY/Getty Images
RNA

Saliva Test of 32 Small RNAs Could be Early Autism Diagnostic

Load more

New Products

View More
Load more
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up